首页> 外文期刊>Journal of the Indian Medical Association. >Evaluation of efficacy and tolerability of RB tone forte tablet in the treatment of pregnancy anaemia.
【24h】

Evaluation of efficacy and tolerability of RB tone forte tablet in the treatment of pregnancy anaemia.

机译:RB替补片治疗妊娠贫血的疗效和耐受性评估。

获取原文
获取原文并翻译 | 示例
       

摘要

In India < 90% of anaemia cases are estimated to be due to iron deficiency, because high iron requirements during pregnancy are not easily fulfilled by dietary intake. Ferrous ascorbate is widely prescribed iron salt in India but still no trial of ferrous ascorbate in Indian patients has been published. The study is to aim the evaluation of efficacy and tolerability of RB Tone forte tablet in the treatment of pregnancy anaemia. Fifty-five pregnant women (> 18 years) with haemoglobin value between 8 and 11 g/dl in 13th week of pregnancy were included in the study. The duration of study was 6 months. Study drug RB Tone forte tablet, (Medley pharmaceutical, Mumbai) containing ferrous ascorbate equivalent to elemental iron 100 mg + folic acid 1.5 mg + elemental zinc 22.5 mg was prescribed once daily to all pregnant women from 13th week of pregnancy for a duration of 6 months. Haemoglobin was assessed at the beginning of the therapy and at the end of the trial. Study included birth weight and gestational age as outcomes because of a need for more information on the functional consequences of iron supplementation during pregnancy. Tolerability was evaluated based on the global assessment by the investigator and patients on a 3-point scale marked as excellent/good/poor. Fifty patients were included for final analysis, 5 patients lost to follow-up. Haemoglobin levels increased from the mean baseline value of 8.950 +/- 0.1422 g/dl to 11.91 +/- 0.07840 g/dl, with mean increase of 2.964 +/- 0.1624 g/dl at the end of trial (p < 0.0001). Mean birth weight of infants (n = 50) was found to be 3079 +/- 25.10 g. Mean gestational age at the time of delivery was 38 weeks. No preterm delivery was reported, As per investigators assessment about tolerability of trial drug, 48% of patients reported good, 46% excellent and 6% reported poor tolerability. As per patient's assessment about tolerability 92% of patients reported good to excellent tolerability and 8% reported poor tolerability. All patients reported excellent gastro-intestinal tolerability of study drug. Positive effect on pregnancy outcome like gestational age and birth weight is mainly attributed to vasodilating property of ferrous ascorbate and beneficial effect of zinc. Ferrous ascorbate must be preferred as first choice of oral iron salt due to positive effect on haemoglobin value, vasodilating property and superior tolerability.
机译:在印度,据估计少于90%的贫血病例是由于铁缺乏引起的,因为怀孕期间铁的高需求很难通过饮食摄入来满足。在印度,抗坏血酸亚铁被广泛地规定为铁盐,但印度抗坏血酸亚铁的试验尚无公开。该研究旨在评估RB Tone forte片剂在治疗孕妇贫血中的功效和耐受性。在研究的第13周,有55名孕妇(> 18岁)的血红蛋白值在8至11 g / dl之间。研究时间为6个月。从怀孕第13周起,所有孕妇每天一次服用含等于抗坏血酸亚铁100 mg +叶酸1.5 mg +元素锌22.5 mg的研究药物RB Tone forte片剂(孟买,孟买)。几个月。在治疗开始和试验结束时评估血红蛋白。由于需要更多有关怀孕期间补铁功能后果的信息,因此研究将出生体重和胎龄作为结果。根据研究者和患者的总体评估,以3分制,即“好/好/差”,对耐受性进行了评估。纳入50例患者进行最终分析,其中5例患者失访。血红蛋白水平从平均基线值8.950 +/- 0.1422 g / dl增加到11.91 +/- 0.07840 g / dl,试验结束时平均增加2.964 +/- 0.1624 g / dl(p <0.0001)。婴儿的平均出生体重(n = 50)为3079 +/- 25.10 g。分娩时的平均胎龄为38周。据报道,没有早产。根据研究者对试验药物耐受性的评估,48%的患者报告良好,46%的患者优良,6%的患者耐受性差。根据患者对耐受性的评估,有92%的患者报告了良好至优异的耐受性,而8%的患者报告了较差的耐受性。所有患者均报告研究药物具有极好的胃肠道耐受性。对妊娠结果如胎龄和出生体重的积极影响主要归因于抗坏血酸亚铁的血管舒张特性和锌的有益作用。由于抗坏血酸亚铁对血红蛋白值,血管舒张性和优异的耐受性具有积极作用,因此必须优先选择抗坏血酸亚铁作为口服铁盐的首选。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号